COVID-19 Vaccine: European regulator asks caution on Sputnik V Ruchika Sharma8 March 2021 11:56 AMZurich: A senior European Medicines Agency (EMA) official urged European Union members on Sunday to refrain from granting national approvals for...
Sputnik V could be third COVID-19 vaccine for India: Experts MD Bureau7 March 2021 3:45 AMNew Delhi: To cater to the vaccination process of the world's largest democracy, it would be pertinent to bring in safer and more effective...
Submit more immunogenicity, safety data on Sputnik V vaccine: CDSCO panel to Dr Reddys Ruchika Sharma25 Feb 2021 7:08 AMOnce Dr Reddy's Labs submits the data, its Emergency Use Authorization application will be considered," a source said.
Dr Reddy's labs begins Sputnik V Emergency Use Authorization process Ruchika Sharma20 Feb 2021 7:58 AMSputnik V maintained a consistent efficacy at 91.8% even among the group of 2, 144 volunteers over 60 year old.
Sputnik V shows 91.6 percent efficacy in Phase III clinical trial: RDIF Ruchika Sharma4 Feb 2021 4:30 AMNew Delhi: The Gamaleya National Research Centre and the Russian Direct Investment Fund (RDIF) on Tuesday said that interim results of a Phase III...
Dr Reddys likely to launch Sputnik V in India in March MD Bureau31 Jan 2021 5:30 AMHyderabad: Dr Reddy's Laboratories Ltd hopes to launch Russian Covid vaccine Sputnik V in India in March after obtaining Emergency Use...
Russian COVID-19 vaccine Sputnik V approved in UAE for emergency use Ruchika Sharma24 Jan 2021 4:00 AMDubai: The UAE health ministry on Thursday approved Russia's Sputnik V COVID-19 vaccine for emergency use, state media reported, as infection levels...
Covid-19: Russia files to register Sputnik V vaccine in Europe Ruchika Sharma21 Jan 2021 3:30 AMThe Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA...
NIMHANS virologist Dr Vasanthapuram Ravi on Sputnik vaccine advisory board Medical Dialogues Bureau20 Jan 2021 4:30 AMIndia is represented on the board by Dr Vasanthapuram Ravi, Dean, Basic Sciences, National Institute of Mental Health and Neurosciences (NIMHANS).
DCGI approves Dr Reddys Phase 3 Sputnik V clinical trial in India Ruchika Sharma16 Jan 2021 7:03 AMHyderabad: Dr. Reddy's Laboratories Ltd has recently announced that the company has received approval from the Drugs Control General of India (DCGI)...
Russian COVID vaccine: Sputnik V meets primary safety endpoint in Phase 2 Clinical Trial in India Ruchika Sharma12 Jan 2021 7:02 AMThe safety data has been submitted to the Drugs Controller General of India (DCGI) for review and approval to continue phase 3 clinical trials.
COVID-19 vaccine main candidates - Where they stand Ruchika Sharma11 Jan 2021 7:53 AMNew Delhi: Almost a year into the Covid-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several...
